LBO — TEXAS HEALTH KAUFMAN
IRR: 16.2% | MOIC: 2.12x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.2%
IRR
2.12x
MOIC
$58.4M
Entry EV
$86.7M
Exit EV
$30.0M
Equity Invested
Sources & Uses
S&UTotal · $58.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $22.7M | 38.8% | |
| Sub Debt | $5.7M | 9.7% | |
| Equity | $30.0M | 51.5% | |
| Enterprise Value | $56.7M | 97.1% | |
| Transaction Fees | $1.7M | 2.9% | |
| Total Uses | $58.4M | 100.0% |
Interpretation
INTAt 2.12x MOIC and 16.2% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $8.3M |
| Exit Ev | $86.7M |
| Net Debt At Exit | $23.0M |
| Equity At Exit | $63.8M |
| Equity Invested | $30.0M |
| Total Value Created | $33.7M |
| Value From Growth | $27.2M |
| Value From Multiple | $2.8M |
| Value From Deleveraging | $5.4M |